e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Different patterns of diffuse parenchymal lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Changes in pulmonary
18
F-FDG SUVmax reflect treatment response in patients with diffuse parenchymal lung disease; a PET/CT proof of concept study
T. Win, N. Screaton, I. Kayani, M. Shastry, R. Endozo, R. Shortman, B. Hutton, P. Ell, A. Groves (Stevenage, Cambridge, United Kingdom)
Source:
Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Session:
Different patterns of diffuse parenchymal lung disease
Session type:
Thematic Poster Session
Number:
818
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Win, N. Screaton, I. Kayani, M. Shastry, R. Endozo, R. Shortman, B. Hutton, P. Ell, A. Groves (Stevenage, Cambridge, United Kingdom). Changes in pulmonary
18
F-FDG SUVmax reflect treatment response in patients with diffuse parenchymal lung disease; a PET/CT proof of concept study. Eur Respir J 2010; 36: Suppl. 54, 818
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
MRI metric lung parenchyma T1 indicates lung pathology in patients with pulmonary hypertension.
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021
Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis: an F-MISO PET/CT study
Source: Eur Respir J, 58 (4) 2004584; 10.1183/13993003.04584-2020
Year: 2021
Predictive value of 18F-FDG PET/CT for chemotherapy-related acute exacerbation of interstitial lung disease in lung cancer patients with interstitial lung disease
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019
HRCT in the diagnosis of diffuse lung disease - overlap issues
Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Year: 2010
The correlation between pathological findings of transbronchial lung cryobiopsy and high resolution CT morphology for diffuse parenchymal lung disease patients
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Year: 2018
The effect of emphysema in patients with idiopathic pulmonary fibrosis; evaluation using quantitative CT analysis
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
18
F-FDG-PET/CT appearances in pulmonary fibrosis; initial experience
Source: Annual Congress 2008 - New imaging techniques in chest imaging
Year: 2008
Prediction of survival in interstitial lung disease (ILD); role of DTPA lung clearance scans and lung function variables
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Understanding the relationship between percentage emphysema as assessed by volumetric CT and lung function in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Textural analysis demonstrates heterogeneous [
18
F]-fluorodeoxyglucose uptake in radiologically normal lung in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J, 52 (5) 1801138; 10.1183/13993003.01138-2018
Year: 2018
Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020
Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension
Source: Eur Respir J, 55 (6) 2000041; 10.1183/13993003.00041-2020
Year: 2020
Paradoxically normal lung volume assessed by CXR and total lung capacity in patients with diffuse pulmondary fibrosis and additional emphysema
Source: Eur Respir J 2006; 28: Suppl. 50, 98s
Year: 2006
The Value of 18F-FDG PET/CT in evaluating disease severity in idiopathic pulmonary fibrosis
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017
Correlation of high resolution CT patterns to pulmonary function tests in patients with interstitial lung diseases
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Pulmonary ANCA-associated vasculitis mimicking a lung tumour or diffuse lung metastases (with positive PET-CT scan)
Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon
Year: 2018
The role of computed tomography in differential diagnosis of pulmonary TB in patients with chronic renal failure in the terminal stage.
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018
Computed tomography lung parenchymal descriptions in routine radiological reporting have diagnostic and prognostic utility in patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension associated with lung disease
Source: ERJ Open Res, 8 (1) 00549-2021; 10.1183/23120541.00549-2021
Year: 2022
Lung cancer in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2001; 17: 1216-1219
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept